Kyntheum

DESCRIPTION

Kyntheum® is a fully human monoclonal antibody and the only biologic treatment
for moderate to severe plaque psoriasis that selectively targets the IL-17 receptor subunit A2,3
This means that it blocks multiple IL-17 cytokines with an active role in the pathogenesis of plaque psoriasis2,3

COMPLETE CLEARANCE WITH KYNTHEUM®
INDUCTION WAS SUSTAINED
THROUGH TO ONE YEAR.1

kyntheum traitment evolution baseline

Baseline

kyntheum traitment evolution week 4

4 weeks

kyntheum traitment evolution week 12

12 weeks

kyntheum traitment evolution week 24

24 weeks